Return to Search
Correction to Processing When Osteoporosis Drugs Are Billed for Other Indications
This Change Request (CR) permanently removes an edit requiring osteoporosis drugs to be billed only by home health agencies.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 20, 2022
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.